Document is current
Any future updates will be listed below
-
Authors
Kumuthini, Judit https://orcid.org/0000-0002-8008-1917
Zick, Brittany
Balasopoulou, Angeliki
Chalikiopoulou, Constantina
Dandara, Collet https://orcid.org/0000-0002-5925-4895
El-Kamah, Ghada
Findley, Laura
Katsila, Theodora https://orcid.org/0000-0002-6263-4231
Li, Rongling
Maceda, Ebner Bon https://orcid.org/0000-0001-5414-7030
Monye, Henrietta
Rada, Gabriel
Thong, Meow-Keong https://orcid.org/0000-0002-7288-7910
Wanigasekera, Thilina
Kennel, Hannah
Marimuthu, Veeramani
,
Williams, Marc S. https://orcid.org/0000-0001-6165-8701
Al-Mulla, Fahd https://orcid.org/0000-0001-5409-3829
Abramowicz, Marc https://orcid.org/0000-0003-0623-8768
-
Funding
Funding for this research was provided by:
National Human Genome Research Institute (U24HG006941.)
- License Information
-
More Information
Article History
Received: 3 February 2022
Accepted: 26 March 2022
First Online: 30 April 2022
Declarations
:
: GPP is Full Member and National Representative at the European Medicines Agency, Committee for Human Medicinal Products (CHMP)—Pharmacogenomics Working Party, Amsterdam, the Netherlands.
